Capcom Falters As Resident Evil 7 and Monster Hunter XX Come in Below Expectations
The publisher had three games in the quarter, but none hit estimates.
This article first appeared on USgamer, a partner publication of VG247. Some content, such as this article, has been migrated to VG247 for posterity after USgamer's closure - but it has not been edited or further vetted by the VG247 team.
Capcom announced its financial earnings report for the fiscal year ended on March 31, 2017, but the news wasn't amazing. Net sales and revenue were up for the company year-over-year, but more importantly, all of the publisher's major releases missed expectations.
Original estimates for the fiscal year saw Resident Evil 7 selling 4 million copies, alongside Monster Hunter XX and Dead Rising 4 with 2 million sold each. Instead, Resident Evil 7 came in around 3.5 million copies sold, Monster Hunter XX sold 1.7 million on 3DS, and Dead Rising 4 landed somewhere below 1 million units. For Resident Evil 7 and Monster Hunter XX, Capcom fell a bit short of expectations, but Dead Rising 4 was a major miss for the company.
"Resident Evil 7 biohazard gave an overall solid performance, while Monster Hunter XX is off to a promising start following its March 2017 release," said the company in its earnings release. "On the other hand, Dead Rising 4 and Monster Hunter Stories underperformed."
In addition, Street Fighter V only moved another 100,000 units during the quarter, with sales coming in at 1.6 million in total.
In the coming fiscal year, Capcom has Marvel vs. Capcom: Infinite, Ultra Street Fighter II: The Final Challengers, Great Ace Attorney 2, and additional Street Fighter V content planned for release. Hopefully, the company has a strong E3 with a host of new, exciting titles.